Literature DB >> 14566086

Decreased plasma adiponectin levels in young obese males.

Taketaka Hara1, Hiroshi Fujiwara, Tetsuo Shoji, Tatsuya Mimura, Hayato Nakao, Shigeo Fujimoto.   

Abstract

Plasma adiponectin levels are reduced in middle-aged obesity and in patients with type 2 diabetes and coronary artery disease. The purpose of this study was to investigate the effects of early-aged obesity on plasma adiponectin level. Twenty-six male college students (19.2 +/- 1.1 years, obese group: n = 15, [body mass index > 25, percent body fat > 25%], non-obese group: n = 11) participated in the present study. We measured anthropometric parameters and plasma adiponectin and leptin level. Plasma adiponectin levels in the obese group were significantly lower than those in the non-obese group (obese: 4.7 +/- 2.0 micro g/ml, non-obese: 6.8 +/- 2.2 micro g/ml, p < 0.05). On the other hand, plasma leptin levels in the obese group were significantly higher than those in the non-obese group (obese: 8.4 +/- 3.2 ng/ml, non-obese: 2.6 +/- 2.1 ng/ml, p < 0.001). Plasma adiponectin levels were significantly correlated with body weight (r = -0.415, p < 0.05) and percent body fat (r = -0.412, p < 0.05). Stepwise multiple regression analysis revealed that percent body fat was a significant independent predictor of plasma adiponectin level (r = 0.406, p < 0.05). These results show that obesity is associated with reduced plasma adiponectin even in young subjects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14566086     DOI: 10.5551/jat.10.234

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  9 in total

1.  Body composition is related to increase in plasma adiponectin levels rather than training in young obese men.

Authors:  Taketaka Hara; Hiroshi Fujiwara; Hayato Nakao; Tatsuya Mimura; Takahiro Yoshikawa; Shigeo Fujimoto
Journal:  Eur J Appl Physiol       Date:  2005-06-08       Impact factor: 3.078

2.  Adiponectin as a protective factor in hepatic steatosis.

Authors:  Nahum Mendez-Sanchez; Norberto-C Chavez-Tapia; Antonio-R Villa; Karla Sanchez-Lara; Daniel Zamora-Valdes; Martha-H Ramos; Misael Uribe
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

3.  Metabolic syndrome and cardiovascular risk.

Authors:  Abdullah M Alshehri
Journal:  J Family Community Med       Date:  2010-05

4.  Gender-specific associations between ADIPOQ gene polymorphisms and adiponectin levels and obesity in the Jackson Heart Study cohort.

Authors:  Pia Riestra; Samson Y Gebreab; Ruihua Xu; Rumana J Khan; Aurelian Bidulescu; Adolfo Correa; Fasil Tekola-Ayele; Sharon K Davis
Journal:  BMC Med Genet       Date:  2015-08-20       Impact factor: 2.103

5.  The combined effects of physical exercise training and detraining on adiponectin in overweight and obese children.

Authors:  Jae-Young Jeon; Jin Han; Hyun-Jun Kim; Moon Soo Park; Dae Yun Seo; Yi-Sub Kwak
Journal:  Integr Med Res       Date:  2013-10-09

6.  Pre- and post- prandial appetite hormone levels in normal weight and severely obese women.

Authors:  Joseph J Carlson; Amy A Turpin; Gail Wiebke; Steven C Hunt; Ted D Adams
Journal:  Nutr Metab (Lond)       Date:  2009-08-11       Impact factor: 4.169

7.  Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in C-reactive protein or fibrinogen.

Authors:  Luis Mauro Alvim de Lima; Nicolas Wiernsperger; Luiz Guilherme Kraemer-Aguiar; Eliete Bouskela
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

8.  Cardiomyocyte Antihypertrophic Effect of Adipose Tissue Conditioned Medium from Rats and Its Abrogation by Obesity is Mediated by the Leptin to Adiponectin Ratio.

Authors:  Suresh C Bairwa; Venkatesh Rajapurohitam; Xiaohong Tracey Gan; Rabban Mangat; Spencer D Proctor; Morris Karmazyn
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

9.  Melatonin improves cardiac function in a mouse model of heart failure with preserved ejection fraction.

Authors:  Yuan Liu; Li-Na Li; Sen Guo; Xiao-Yan Zhao; Yu-Zhou Liu; Cui Liang; Sheng Tu; Dan Wang; Ling Li; Jian-Zeng Dong; Lu Gao; Hai-Bo Yang
Journal:  Redox Biol       Date:  2018-07-11       Impact factor: 11.799

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.